Advertisement

Intermediary Metabolism of Carbohydrate, Protein, and Fat

  • Keith Tornheim
  • Neil B. Ruderman
Chapter

Abstract

The causes of obesity in an individual may involve many factors, both genetic and environmental, including fat cell production and development, appetite and energy regulation. However, the excessive accumulation of triglyceride (triacylglycerol) that characterizes obesity and its effects on the use and storage of various fuels (glucose, fatty acids, and amino acids) are clearly the result of abnormalities in metabolism. The pathways of carbohydrate, protein, and fat metabolism and their interactions and regulatory mechanisms are described, including effects of insulin and counterregulatory hormones such as glucagon and epinephrine. Fructose, incorporated increasingly in the diet, has relatively unregulated metabolism compared with glucose and may thus promote obesity. New insights that have been obtained from studies of genetic models with oblation or modification of particular enzymes or hormone receptors often in a tissue-specific manner are presented, in particular the insulin receptor and the insulin-stimulated glucose transporter Glut4 of muscle and fat cells. The enzyme AMP-activated protein kinase (AMPK) is probably of central importance, as it has recently been identified as a cellular mediator of many events in intermediary metabolism and whose dysregulation may be a cause of disorders associated with the metabolic syndrome and a target for their therapy.

Keywords

Fatty Acid Oxidation Fatty Acid Synthesis Citric Acid Cycle Pyruvate Carboxylase Hormone Sensitive Lipase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Matschinsky, F., Liang, Y., Kesavan, P., et al. (1993). Glucokinase as pancreatic β cell glucose sensor and diabetes gene. Journal of Clinical Investigation, 92, 2092–2098.CrossRefPubMedGoogle Scholar
  2. 2.
    Zorzano, A., Balon, T.W., Brady, L.J., et al. (1985). Effects of starvation and exercise on concentrations of citrate. hexose phosphates and glycogen in skeletal muscle and heart. Evidence for selective operation of the glucose-fatty acid cycle. Biochemical Journal, 232, 585–591.PubMedGoogle Scholar
  3. 3.
    Atsumi, T., Nishio, T., Niwa, H., et al. (2005). Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation. Diabetes, 54, 3349–3357.CrossRefPubMedGoogle Scholar
  4. 4.
    Huo, Y., Guo, X., Honggui, L., et al. (2010). Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates sustemic insulin resistance and adipose tissue inflammatory response. Journal of Biological Chemistry, 285, 3713–3721.CrossRefPubMedGoogle Scholar
  5. 5.
    Tornheim, K. (1997). Are metabolic oscillations responsible for normal oscillatory insulin secretion? Diabetes, 46, 1375–1380.CrossRefPubMedGoogle Scholar
  6. 6.
    Getty-Kaushik, L., Viereck, J.C., Goodman, J.M., et al. (2010). Mice deficient in phosphofructokinase-M have greatly decreased fat stores. Obesity, 18, 434–440.CrossRefPubMedGoogle Scholar
  7. 7.
    Johnson, R.J., Perez-Pozo, S.E., Sautin, Y.Y., et al. (2009). Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocrine Review, 30, 96–116.CrossRefGoogle Scholar
  8. 8.
    Matsumoto, M., & Accili, D. (2006). The tangled path to glucose production. Nature Medicine, 12, 33–34.CrossRefPubMedGoogle Scholar
  9. 9.
    Vidal-Puig, A., & O’Rahilly, S. (2001). Controlling the glucose factory. Nature, 413, 125–126.CrossRefPubMedGoogle Scholar
  10. 10.
    Aragón, J.J., & Lowenstein, J.M. (1980). The purine-nucleotide cycle: Comparison of the levels of citric acid cycle intermediates with the operation of the purine nucleotide cycle in rat skeletal muscle during exercise and recovery from exercise. European Journal of Biochemistry, 110, 371–377.CrossRefPubMedGoogle Scholar
  11. 11.
    Rothman, D.L., Magnusson, I., Cline, G., et al. (1995). Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proceedings of the National Academy of Science USA, 92, 983–987.CrossRefGoogle Scholar
  12. 12.
    Rossetti, L., & Giaccari, A. (1990). Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake: A dose-response euglycemic clamp study in normal and diabetic rats. Journal of Clinical Investigation, 85, 1785–1792.CrossRefPubMedGoogle Scholar
  13. 13.
    Bollen, M., Keppens, S., Stalmans, W. (1998). Specific features of glycogen metabolism in the liver. Biochemical Journal, 336, 19–31.PubMedGoogle Scholar
  14. 14.
    Yoneshiro, T., Aita, S., Matsushita, M., et al. (2010). Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity [Epub ahead of print].Google Scholar
  15. 15.
    Ravussin, E. (2010). The presence and role of brown fat in adult humans. Current Diabetic Reports, 10, 90–92.CrossRefGoogle Scholar
  16. 16.
    Ahmed, K., Tunaru, S., Tang, C., et al. (2010). An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metabolism, 11, 311–319.CrossRefPubMedGoogle Scholar
  17. 17.
    Richter, E.A., & Ruderman, N.B. (2009). AMPK and the biochemistry of exercise: Implications for human health and disease. Biochemical Journal, 418, 261–275.CrossRefPubMedGoogle Scholar
  18. 18.
    Yaney, G.C., & Corkey, B.E. (2003). Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia, 46, 1297–1312.CrossRefPubMedGoogle Scholar
  19. 19.
    Nye, C.K., Hanson, R.W., Kalhan, S.C. (2008). Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat. Journal of Biological Chemistry, 283, 27565–27574.CrossRefPubMedGoogle Scholar
  20. 20.
    Berg, J.M., Tymoczko, J.L., Stryer, L. (2006). Biochemistry (6th ed.). New York: WH Freeman.Google Scholar
  21. 21.
    Hardie, D.G., & Carling, D. (1997). The AMP-activated protein kinase – fuel gauge of the mammalian cell? European Journal of Biochemistry, 246, 259–273.CrossRefPubMedGoogle Scholar
  22. 22.
    Towler, M.C., & Hardie, D.G. (2007). AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research, 100, 328–341.CrossRefPubMedGoogle Scholar
  23. 23.
    Ruderman, N., & Prentki, M. (2004). AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome. Nature Reviews Drug Discovery, 3, 340–351.CrossRefPubMedGoogle Scholar
  24. 24.
    Ruderman, N.B., Xu, X.J., Nelson, L., et al. (2010). AMPK and SIRT1: A long-standing partnership? American Journal of Physiology: Endocrinology Metabolism, 298, 751–760.CrossRefGoogle Scholar
  25. 25.
    Cantó, C., Jiang, L.Q., Deshmukh, A.S., et al. (2010). Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metabolism, 11, 213–219.CrossRefPubMedGoogle Scholar
  26. 26.
    Filozof, C., & Gonzalez, C. (2000). Predictors of weight gain: The biological-behavioural debate. Obesity Review, 1, 21–26.CrossRefGoogle Scholar
  27. 27.
    Ellis, A.C., Hyatt, T.C., Hunter, G.R., Gower, B.A. (May 6, 2010). Respiratory quotient predicts fat mass gain in premenopausal women. Obesity [Epub ahead of print].Google Scholar
  28. 28.
    Ruderman, N.B., Saha, A.K., Kraegen, E.W. (2003). Minireview: Malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology, 144, S166–S171.CrossRefGoogle Scholar
  29. 29.
    Biddinger, S.B., & Kahn, C.R. (2006). From mice to men: Insights into the insulin resistance syndromes. Annual Review of Physiology, 68, 123–158.CrossRefPubMedGoogle Scholar
  30. 30.
    Herman, M.A., & Kahn, B.B. (2006). Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. Journal of Clinical Investigation, 116, 1767–1775.CrossRefPubMedGoogle Scholar
  31. 31.
    Walsh, K. (2009). Adipokines, myokines and cardiovascular disease. Circulatory Journal, 73, 13–18.CrossRefGoogle Scholar
  32. 32.
    Haller, J.F., Smith, C., Liu, D., et al. (2010). Isolation of novel animal cell lines defective in glycerolipid biosynthesis reveals mutations in glucose-6-phosphate isomerase. Journal of Biological Chemistry, 285, 866–877.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of BiochemistryBoston University School of MedicineBostonUSA

Personalised recommendations